Co-Diagnostics, Inc.
Cash Flow Statement
| Line Item | FY2017 | FY2016 |
|---|---|---|
| Operating Activities | ||
| Net Income | $-7.0M | $-1.9M |
| Depreciation & Amortization | $45.8K | $37.5K |
| Depreciation | $4.9K | $-9.7K |
| Amortization | — | — |
| Stock-Based Compensation | $2.0M | $69.6K |
| Net Cash from Operating Activities | $-3.2M | $-1.3M |
| Investing Activities | ||
| Capital Expenditures | $129.3K | $12.2K |
| Business Acquisitions | — | — |
| Net Cash from Investing Activities | $-189.3K | $-12.2K |
| Financing Activities | ||
| Dividends Paid | — | — |
| Stock Repurchases | — | — |
| Net Cash from Financing Activities | $5.9M | $2.3M |
| Net Change in Cash | $2.5M | $964.9K |
| Free Cash Flow | $-3.3M | $-1.3M |